Arvind Arumainathan
Southampton Hospital(US)Clatterbridge Cancer Centre NHS Foundation Trust(GB)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, Cutaneous lymphoproliferative disorders research, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients(2018)221 cited
- → Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents(2020)83 cited
- → Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐BCRinhibitor setting: aUKwide analysis(2019)78 cited
- → The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia(2019)28 cited
- → The development of sarcoidosis with the use of alemtuzumab – clues to T‐cell immune reconstitution(2007)21 cited
- → Results of a multicentre UK‐wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting(2017)20 cited
- → A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification(2025)13 cited
- → Results of a multicentre UK‐wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma(2017)11 cited
- → U.K. national audit of extracorporeal photopheresis in cutaneous T-cell lymphoma(2017)9 cited
- → Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial(2024)6 cited